Session Description

Transformational leadership through a racial equity lens seeks to provide insight and tools for effective leadership during times of change and challenge. Participants will explore the foundations of transformational leadership, learn the language of healthcare and racial equity, and engage in self-reflection and discussion. Leaders will be inspired to take steps toward creating more equitable work environments, healthcare policies, and systems for diverse organizations and marginalized communities.

Learning Outcomes/Objectives

• Discuss transformational leadership.
• Define healthcare and racial equity.
• Create equitable work environments in healthcare.

Credits: CE: 1.5

View evidence-based poster presentations and earn 1 credit after completing the session evaluation on the Continuing Education tab.

CE credits: 1

Cardiometabolic disease (CMD) is the leading cause of death in this country and currently affects one in three Americans (including healthcare providers). CMD is an ominous condition that leads to broad systemic upheaval and a clustering of cohort conditions (glucose intolerance, insulin resistance, adiposopathy, high blood pressure, atherogenic dyslipidemia, and CKD). This important session will address emerging insights regarding risk; diagnostic biomarkers; and effective, wide-ranging treatment strategies for this deadly disease.

Learning Outcomes/Objectives

• Identify the risks for, and biomarkers of, CMD.
• Discuss the etiology and underlying pathophysiological links between cardiac dysmetabolism, adiposopathy, insulin resistance, fatty liver, kidney disease, and other comorbidities of CMD.
• Safely prescribe, manage, and monitor appropriate pharmacotherapeutics, nutraceuticals, and lifestyle interventions aimed at the three main components of CMD: cardiovascular health (HTN, lipids), glycemic impairment, and adiposity.
• Describe the new concept of cardiovascular-kidney-metabolic (CKM) syndrome and how cardiovascular disease, diabetes, and obesity contribute to kidney disease

Credits: CE 1.5; Rx 1.5.

Vaccine hesitancy is at a historical high. Following the COVID-19 pandemic and the introduction of the COVID-19 vaccine, parents and families have more concerns than ever about vaccine safety and efficacy. As the most trusted professions, nurses and NPs have the education and training to give credible information and effective counsel to parents and families engaging in effective decision making. This session will equip NPs to implement specific strategies in response to vaccine hesitancy.

Learning Outcomes/Objectives

• Review current updates in pediatric vaccination recommendations.
• Describe challenges faced by providers in responding to misinformation.
• Explore effective strategies to respond to parental vaccine hesitancy.

Credits: CE: 1.5; Rx 0.5

In the wake of the opioid crisis, it is incumbent on providers to consider alternative options to pain management. This presentation discusses multiple interventions-with a focus on peripheral nerve blocks- that can limit the use of opioids as well as offer more effective means to manage pain in the post-operative and post-injured patient.

Learning Outcomes/Objectives

• Discuss the advantages and disadvantages of peripheral nerve blocks.
• Discuss the physiology and pharmacology of peripheral nerve blocks.
• Discuss potential complications of peripheral nerve blocks.
• Describe management of the patient undergoing peripheral nerve blockade, including patient education.

Credits: CE: 1.5; Rx 1.5

Highlights of this session include information that will help you hone your prescribing skills in the older adult. Focused on the Beers and START/STOPP criteria as well as recommendations from deprescribing.org, this talk will fill you in not only on what drugs should be avoided but also how to prioritize medications for addition or discontinuation.

Learning Outcomes/Objectives

• Identify the effects of aging on pharmacokinetics and pharmacodynamics.
• Recognize safety issues with the use of select medications in the older adult.
• Describe potentially inappropriate medications, per Beers and START/STOPP criteria as well as deprescribing.org, in prescribing for the older adult.
• Recognize select priority medications to be used in older adults.

Credits: CE: 1.5; Rx: 1.5

This session focuses on cases in which patients have required medication for lipid management. Cases range from the least complicated to the more complex patient, and medication selection aligns with current guidelines.

Learning Outcomes/Objectives

• Apply the most effective medication regimen along with lifestyle management for patients
  requiring lipid-lowering therapy.
• Discuss rationale for lipid lowering medications along with potential side effects from and
  expected outcomes of the therapy.
• Understand when particularly complicated patients should be referred to a lipid specialist for
  recommendations.

Credits: CE: 1.5; Rx: 1.5

Join us for an engaging session about the latest updates and guidelines for concussion assessment and treatment. Discussion points incorporate both sports-related concussion and other common causes of this mild traumatic brain injury. Did you know that evidence supports aerobic exercise as a treatment for post-concussion syndrome? This presentation reviews both pharmacologic and nonpharmacologic treatment.

Learning Outcomes/Objectives

• Review current epidemiology related to concussion, including the top three causes of this diagnosis.
• Identify four evidence-based acute history and examination methods for concussion.
• Discuss three pharmacologic and three nonpharmacologic treatment modalities for concussion.

Credits: CE: 1.5

Aging is associated with increased risk factors for a number of diseases including dementia. Screening for clinical competency is important for safety as well as disease management. This presentation explores clinical evaluation, common profiles, and common cognitive assessment tools for dementia. Driving and medication administration considerations will also be discussed.

Learning Outcomes/Objectives

• Identify at least two essential elements in the clinical evaluation of dementia.
• Recall at least two cognitive assessment tools for dementia.
• Identify at least one action item when driving safety is of concern in an older adult.

Credits: CE: 1.5

Most mental health concerns first present in primary care, placing the primary care nurse practitioner in a visible and critical position to screen, diagnose, and treat common mood disorders. This session will focus on major depression, anxiety, bipolar, and somatic symptom disorders, in a primary care setting, providing an overview regarding screening, diagnostic, and intervention recommendations.

Learning Outcomes/Objectives

• Described the presentation of depression and anxiety disorders in adults.
• Compare at least one method of screening available for adults with depression, anxiety, and OCD symptoms.
• Describe pharmacological and non-pharmacological treatment strategies for adults diagnosed with anxiety, OCD, and depressive disorders in primary care.

Credits: CE: 1.5; Rx: 0.5

This session will review the 12-Lead ECG with specific details regarding acute changes that need immediate attention.

Learning Outcomes/Objectives

• Review 12-Lead ECGs.
• Identify acute changes.

Credits: CE: 1.5